Cardinal Health (CAH) PT Raised to $160 at UBS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts CAH Hot Sheet
Price: $252.94 --0%
Rating Summary:
18 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Rating Summary:
18 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Join SI Premium – FREE
UBS analyst Kevin Caliendo raised the price target on Cardinal Health (NYSE: CAH) to $160.00 (from $150.00) while maintaining a Buy rating.
You May Also Be Interested In
- Cardinal Health (CAH) PT Raised to $286 at Morgan Stanley
- Rhythm Pharmaceuticals (RYTM) PT Lowered to $146 at Morgan Stanley
- Waters Corp. (WAT) PT Raised to $500 at KeyBanc
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
